Gene therapy shows promise in restoring vision by directly targeting cells in the eye. This innovative treatment involves an injection delivered into the eye, specifically aiming to reactivate ganglion cells. These cells are vital for recognizing light. Successfully reactivated, these cells regain the ability to detect light signals. This breakthrough offers potential hope for individuals with vision loss due to retinal cell damage. This offers hope for those experiencing various visual impairments, potentially restoring functionality in the eye. Further research will determine the long-term efficacy and widespread applicability of this therapy.